-
Identification and Management of Behavioral Symptoms and Mental Health Conditions in Individuals with Intellectual Disabilities (R01 - Clinical Trial Optional)
(PAR-18-766)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Small Research Grant Program for the Next Generation of Clinical Researchers in Alzheimer's Disease (AD) and Alzheimers Disease Related Dementias (ADRD) Research (R03 Clinical Trial Optional)
(RFA-AG-19-002)
National Institute on Aging
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): July 3, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Small Research Grant Program for the Next Generation of Researchers in Basic Alzheimer's Disease (AD) and Alzheimers Disease Related Dementias (ADRD) Research (R03 Clinical Trial Not Allowed)
(RFA-AG-19-003)
National Institute on Aging
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): July 3, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Advancing HIV Therapeutic Vaccine Science (U01 Clinical Trial Required)
(RFA-AI-18-015)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): September 27, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Improving the Reach and Quality of Cancer Care in Rural Populations (R01 Clinical Trial Required)
(RFA-CA-18-026)
National Cancer Institute
Application Receipt Date(s): September 19, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
SBIR E-learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)
(RFA-ES-18-006)
National Institute of Environmental Health Sciences
Application Receipt Date(s): July 31, 2018, by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Cooperative Agreement to Support Regulatory Research Related to the 2018 Prescription Drug User Fee Act and the 21st Century Cures Act
(RFA-FD-18-013)
Food and Drug Administration
Application Receipt Date(s): June 25, 2018, by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
-
Strengthen Regulatory Systems to Ensure the Safety and Quality of Food and Medical Products (U01)
(RFA-FD-18-022)
Food and Drug Administration
Application Receipt Date(s): August 1, 2018, by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
-
T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed)
(RFA-HL-19-023)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): September 4, 2018; February 26, 2019; September 4, 2019; February 26, 2020; September 4, 2020; February 26, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NIH Director's Pioneer Award (DP1 - Clinical Trial Optional)
(RFA-RM-18-007)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): September 14, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.
NIH Grants and Funding
Warning! This browser is not supported - Some features might not work. Try using a different browser such as Chrome, Edge, Firefox, or Safari.
NIH Staff 
